Kamilė Čerlinskaitė‐Bajorė

Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial

Pierre‐François Laterre, Peter Pickkers, Gernot Marx et al. · Intensive Care Medicine · 2021 · 92 citations · Full text

Veterinary Medicine, Immunology, Pharmacology +15

NT-proBNP and high intensity care for acute heart failure: the STRONG-HF trial

Marianna Adamo, Matteo Pagnesi, Alexandre Mebazaa et al. · European Heart Journal · 2023 · 62 citations · Full text

Medicine, Cardiology, Internal Medicine +14

Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HF

Jan Biegus, Alexandre Mebazaa, Beth A. Davison et al. · Journal of the American College of Cardiology · 2024 · 47 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +5

Safety, Tolerability and Efficacy of Up-Titration of Guideline-Directed Medical Therapies for Acute Heart Failure in Elderly Patients: A Sub-Analysis of the STRONG-HF Randomized Clinical Trial

Mattia Arrigo, Jan Biegus, Ayu Asakage et al. · European Journal of Heart Failure · 2023 · 42 citations · Full text

Medicine, Cardiology, Geriatric Medicine +13

Non-Cardiac Comorbidities and Intensive Up-Titration of Oral Treatment in Patients Recently Hospitalized for Heart Failure: Insights from the STRONG-HF Trial

Ovidiu Chioncel, Beth A. Davison, Marianna Adamo et al. · European Journal of Heart Failure · 2023 · 31 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +10